Pimavanserin Treatment for Parkinson's Disease Psychosis in Clinical Practice

BACKGROUND: Parkinson's disease psychosis (PDP) is a common, nonmotor symptom of Parkinson's disease (PD), which may affect up to 60% of patients and is associated with impaired quality of life, increased healthcare costs, and nursing home placement, among other adverse outcomes. Character...

Descripción completa

Detalles Bibliográficos
Autores principales: Dashtipour, Khashayar, Gupta, Fiona, Hauser, Robert A., Karunapuzha, Cherian A., Morgan, John C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801085/
https://www.ncbi.nlm.nih.gov/pubmed/33489083
http://dx.doi.org/10.1155/2021/2603641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801085/
https://www.ncbi.nlm.nih.gov/pubmed/33489083
http://dx.doi.org/10.1155/2021/2603641

Ejemplares similares